Skip to main content
. 2017 Oct;9(10):3703–3710. doi: 10.21037/jtd.2017.09.10

Table 2. Expression of MMP9, TIMP1 and PPAR-γ of COPD patients with different pulmonary functional impairment.

Analyte Group I Group II Group III Group IV F P
PPAR-γ (ng/L) 132.64±20.42 128.62±23.62 119.11±21.93 103.68±27.87 3.28 0.045
TIMP1 (U/L) 107.85±17.25 99.51±16.63 86.84±14.53 82.15±8.40 6.22 0.004
MMP9 (μg/L) 16.83±3.34 17.16±4.55 17.49±8.67 25.55±9.87 3.69 0.031
MMP9/TIMP1 0.13±0.05 0.18±0.07 0.21±0.13 0.31±0.13 3.78 0.29